Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Christoph L. Bausch"'
Autor:
Sergei S. Biryukov, Hua Wu, Jennifer L. Dankmeyer, Nathaniel O. Rill, Christopher P. Klimko, Kristi A. Egland, Jennifer L. Shoe, Melissa Hunter, David P. Fetterer, Ju Qiu, Michael L. Davies, Christoph L. Bausch, Eddie J. Sullivan, Thomas Luke, Christopher K. Cote
Publikováno v:
Antibodies, Vol 12, Iss 2, p 33 (2023)
Plague is an ancient disease that continues to be of concern to both the public health and biodefense research communities. Pneumonic plague is caused by hematogenous spread of Yersinia pestis bacteria from a ruptured bubo to the lungs or by directly
Externí odkaz:
https://doaj.org/article/78b48d9176544b89af0bfb57695e213c
Autor:
Zhuoming Liu, Hua Wu, Kristi A. Egland, Theron C. Gilliland, Matthew D. Dunn, Thomas C. Luke, Eddie J. Sullivan, William B. Klimstra, Christoph L. Bausch, Sean P. J. Whelan
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 2 (2022)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with amino-acid substitutions and deletions in spike protein (S) can reduce the effectiveness of monoclonal antibodies (mAbs) and may compromise immunity induced by vaccines. We re
Externí odkaz:
https://doaj.org/article/e29eb5cbee9140b8aba60e64edfb7434
Autor:
Juanjie, Tang, Gabrielle, Grubbs, Youri, Lee, Hua, Wu, Thomas C, Luke, Kristi A, Egland, Christoph L, Bausch, Eddie J, Sullivan, Surender, Khurana
Publikováno v:
The Journal of Infectious Diseases. 226:655-663
Passive antibody immunotherapeutics directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are promising countermeasures for protection and treatment of coronavirus disease 2019 (COVID-19). SARS-CoV-2 variants of concern (VOCs)
SAB-185 is a fully human polyclonal anti-SARS-CoV-2 immunoglobulin produced from the plasma of transchromosomic bovines that are hyperimmunized with recombinant SARS-CoV-2 Wuhan-Hu-1 Spike protein. SAB-185 is being evaluated for efficacy in aphase 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62ba267453244bf63e81d9cf89fd8d47
https://doi.org/10.1101/2021.08.09.454215
https://doi.org/10.1101/2021.08.09.454215
Autor:
Yutaka Terada, Maria Alcorn, Kristi A Egland, Theron Gilliland, Deanna Larson, Zhongde Wang, Shauna N. Vasilatos, Jeneveve D. Lundy, Eddie Sullivan, Thomas C. Luke, Rong Li, Christoph L Bausch, Zachary Ryckman, William B. Klimstra, Hua Wu, Emily L. Cottle, Matthew D. Dunn, Yanan Liu
Publikováno v:
bioRxiv
Pandemic SARS CoV-2 has been undergoing rapid evolution during spread throughout the world resulting in the emergence of many Spike protein variants, some of which appear to either evade antibody neutralization, transmit more efficiently, or potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::183762c2dce43cd4bc3df746229a45c1
https://doi.org/10.1101/2021.07.26.453840
https://doi.org/10.1101/2021.07.26.453840
Autor:
Eddie Sullivan, Zhuoming Liu, Christoph L Bausch, Kristi A Egland, Theron C. Gilliland, Thomas C. Luke, Sean P. J. Whelan, Hua Wu, Matthew D. Dunn, William B. Klimstra
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with amino-acid substitutions and deletions in spike protein (S) can reduce the effectiveness of monoclonal antibodies (mAbs) and may compromise immunity induced by vaccines. We re
Autor:
Colin Brunick, Adam D. Hoppe, Victor C. Huber, Eddie Sullivan, Chithra C. Sreenivasan, Bin Zhou, Feng Li, Dan Wang, David E. Wentworth, Dana Rausch, Ben M. Hause, Travis Clement, Christoph L Bausch, Rongyuan Gao, Hua Wu, Zizhang Sheng, Jane Christopher-Hennings
Publikováno v:
J Virol
Influenza remains a global health risk and challenge. Currently, neuraminidase (NA) inhibitors are extensively used to treat influenza, but their efficacy is compromised by the emergence of drug-resistant variants. Neutralizing antibodies targeting i
Autor:
Melanie V. Cohen, Joshua D. Shamblin, Jay W. Hooper, Eddie Sullivan, Rebecca L. Brocato, Padmanabh Chivukula, Lucia M. Principe, Brandon Somerville, Christoph L Bausch, Steven A. Kwilas, Jerel Vega, Priya Karmali, Hua Wu, Casey C. Perley
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Frontiers in Microbiology
Frontiers in Microbiology
We explored an emerging technology to produce anti-Hantaan virus (HTNV) and anti-Puumala virus (PUUV) neutralizing antibodies for use as pre- or post-exposure prophylactics. The technology involves hyperimmunization of transchomosomic bovines (TcB) e
Autor:
Trissa Borgschulte, Matthew V. Caple, Kevin Kayser, Daniel W. Allison, Christoph L. Bausch, Florian M. Wurm, David L. Hacker, Fanny Delegrange
Publikováno v:
Cells and Culture ISBN: 9789048134182
Chinese Hamster Ovary (CHO) cells are one of the most widely used cell lines for the production of recombinant therapeutic proteins. In an effort to better understand the molecular characteristics of high-producing CHO clones, we developed a high thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85515d28ef1bf662c414fcc5bbee7895
https://doi.org/10.1007/978-90-481-3419-9_1
https://doi.org/10.1007/978-90-481-3419-9_1